Retour
25
14
30
24
24
Fourchette du Jour
11,00 €
11,00 €
Fourchette 52 Semaines
8,79 €
11,46 €
Volume
1 000
Moyenne 50J / 200J
10,75 €
/
10,17 €
Clôture Précédente
11,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 3,3 | 0,2 |
| P/B | 0,8 | 3,0 |
| ROE % | 21,9 | 3,6 |
| Net Margin % | 21,6 | 3,8 |
| Rev Growth 5Y % | 18,3 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
1,84B | 0 |
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
1,64B | 0 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-31 | N/A | 0,11 € | — |
| 2025-10-20 | N/A | 0,07 € | — |
| 2025-07-18 | N/A | 0,09 € | — |
| 2025-05-07 | N/A | 0,79 € | — |
| 2025-02-12 | N/A | 0,81 € | — |
| 2024-10-22 | N/A | 0,36 € | — |
| 2024-07-23 | N/A | 1,10 € | — |
| 2024-05-07 | N/A | 1,21 € | — |
Dividend History
7 yr streakYield
0,07%
Payout Ratio
2,10%
Growth (3Y)
-1,36%
Growth (5Y)
30,03%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 09, 2025 | May 29, 2025 | 0,71 € | 6,55% |
| May 09, 2024 | May 30, 2024 | 0,64 € | 5,52% |
| May 08, 2023 | May 30, 2023 | 0,28 € | 3,34% |
| May 09, 2022 | May 31, 2022 | 0,74 € | 2,66% |
| May 07, 2021 | Jun 01, 2021 | 0,20 € | 0,80% |
| May 08, 2020 | May 29, 2020 | 0,19 € | 0,76% |
| May 09, 2019 | May 30, 2019 | 0,52 € | 2,16% |
| Apr 26, 2018 | May 18, 2018 | 0,51 € | 2,20% |
| May 03, 2017 | May 25, 2017 | 0,42 € | 2,21% |
| May 10, 2016 | Jun 01, 2016 | 0,30 € | 5,07% |
| Apr 20, 2016 | Apr 29, 2016 | 0,66 € | 3,48% |
Points Clés
Revenue grew 18,31% annually over 5 years — strong growth
ROE of 21,91% indicates high profitability
Net margin of 21,63% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 302,97M in free cash flow
P/E of 3,26 — trading at a low valuation
Croissance
Revenue Growth (5Y)
18,31%
Revenue (1Y)8,11%
Earnings (1Y)-5,30%
FCF Growth (3Y)-10,38%
Qualité
Return on Equity
21,91%
ROIC23,54%
Net Margin21,63%
Op. Margin26,82%
Sécurité
Debt / Equity
0,00
Current Ratio6,12
Interest Coverage48,84
Valorisation
P/E Ratio
3,26
Forward P/EN/A
P/B Ratio0,82
EV/EBITDA0,68
Dividend Yield0,07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,11% | Revenue Growth (3Y) | 8,92% |
| Earnings Growth (1Y) | -5,30% | Earnings Growth (3Y) | -4,56% |
| Revenue Growth (5Y) | 18,31% | Earnings Growth (5Y) | 14,11% |
| Profitability | |||
| Revenue (TTM) | 1,54B | Net Income (TTM) | 332,76M |
| ROE | 21,91% | ROA | 20,83% |
| Gross Margin | 73,37% | Operating Margin | 26,82% |
| Net Margin | 21,63% | Free Cash Flow (TTM) | 302,97M |
| ROIC | 23,54% | FCF Growth (3Y) | -10,38% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 6,12 |
| Interest Coverage | 48,84 | ||
| Dividends | |||
| Dividend Yield | 0,07% | Payout Ratio | 2,10% |
| Dividend Growth (3Y) | -1,36% | Dividend Growth (5Y) | 30,03% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 3,26 | Forward P/E | N/A |
| P/B Ratio | 0,82 | P/S Ratio | 0,70 |
| PEG Ratio | -5,65 | Forward PEG | N/A |
| EV/EBITDA | 0,68 | Fwd EV/EBITDA | 0,47 |
| Forward P/S | 0,66 | Fwd Earnings Yield | N/A |
| FCF Yield | 27,96% | ||
| Market Cap | 1,08B | Enterprise Value | 282,16M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,54B | 1,42B | 1,30B | 1,10B | 785,11M |
| Net Income | 332,76M | 351,39M | 365,35M | 373,77M | 196,27M |
| EPS (Diluted) | 3,29 | 3,48 | 3,62 | 3,70 | 1,94 |
| Gross Profit | 1,13B | 1,03B | 950,19M | 801,93M | 582,95M |
| Operating Income | 412,47M | 423,37M | 443,10M | 361,46M | 253,74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,60B | 2,03B | 2,33B | 2,21B | 2,13B |
| Total Liabilities | 283,59M | 310,07M | 302,85M | 241,55M | 250,69M |
| Shareholders' Equity | 1,31B | 1,72B | 2,03B | 1,97B | 1,88B |
| Total Debt | 0,0 | 29,48M | 8,80M | 20,09M | 10,40M |
| Cash & Equivalents | 801,31M | 1,22B | 1,54B | 1,49B | 1,48B |
| Current Assets | 1,22B | 1,61B | 1,87B | 1,80B | 1,75B |
| Current Liabilities | 199,14M | 206,20M | 195,74M | 164,99M | 126,95M |
Scores de Stratégies
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#917 of 1049
#773 of 826
Custom
Capital Light Compounder
#158 of 220
#420 of 619
#175 of 203
Activité Récente
Sorti
Contrarian Investing (David Dreman)
Mar 26, 2026
Sorti
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026